We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maciej Mrugala MD, PhD, MPH

Maciej M Mrugala MD, PhD, MPH

Alexander M. Spence Endowed Chair in Neuro-Oncology and Associate Professor of Neurology; Executive Co-Director of Clinical Neuro-Oncology, Alvord Brain Tumor Center, University of Washington School of Medicine, Seattle, Washington

Dr. Maciej Mrugala is Alexander M. Spence Endowed Chair in Neuro-Oncology and Associate Professor of Neurology at the University of Washington School of Medicine, where he is also Executive Co-Director of Clinical Neuro-Oncology at the Alvord Brain Tumor Center. He is Chief of the Division of Neuro-Oncology at the University of Washington Medical School Hospitals and Seattle Cancer Care Alliance.

Dr. Mrugala received his medical degree from the University of Warsaw Medical School and his PhD in neurobiology from Copernicus University in Torun, Poland. He completed a neurology residency at the University of Massachusetts Medical School, where he was chief resident. He also completed fellowships in neuro-oncology at Massachusetts General Hospital, and Dana-Farber Cancer Institute in Boston, while concurrently earning an MPH at Harvard School of Public Health.

Dr. Mrugala is a board member of the Washington State Neurological Society and a member of the American Academy of Neurology, the Society for Neuro-Oncology, and the American Society of Clinical Oncologists, among other professional organizations. He is an expert in primary glial brain tumors, primary CNS lymphoma, and neurofibromatosis, with expertise in experimental therapeutics and the complications of treatments in neuro-oncology as well. He is widely published.